InterCare DX, Inc. (ICCO) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerInterCare DX, Inc. (ICCO) trades at $0.0001. InterCare DX, Inc. develops and delivers specialized software solutions with a focus on the biomedical sector, offering applications for relaxation, stress management, and integrated enterprise systems. Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for ICCO: ICCO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
InterCare DX, Inc. (ICCO) Healthcare & Pipeline Overview
InterCare DX, Inc. provides diverse software solutions across healthcare, education, and enterprise sectors, including clinical management, vascular diagnostics, and e-learning platforms. Operating as a subsidiary of Meridian Holdings, Inc., the company leverages multimedia and RFID technologies to deliver specialized applications for various administrative and wellness needs.
What Is the Investment Thesis for ICCO?
InterCare DX, Inc. presents an investment thesis centered on its diverse software solutions catering to growing sectors like healthcare information services, education technology, and corporate wellness. The company's offerings, such as the "InterCare Clinical Explorer" and "e-Learning Integrated Technology Enterprise Systems," address critical needs for operational efficiency and data management in large, complex organizations. The "InterCare Vascular Diagnostic Center" taps into the increasing demand for preventive healthcare technologies. However, the company's extremely low market capitalization of $0.00B and its listing on the 'OTC Other' tier signify substantial financial and regulatory risks, including potential liquidity challenges and limited public disclosure. The negative Beta of -2.49 suggests an inverse relationship with market movements, which can be indicative of unique, company-specific factors or low trading volume. Investors should meticulously evaluate the company's business strategy, compliance efforts, and potential for market penetration for its specialized software solutions against the backdrop of its current financial standing and OTC market limitations.
Based on FMP financials and quantitative analysis
ICCO Key Highlights
InterCare DX, Inc. maintains an extremely low market capitalization of $0.00B, reflecting its early stage or limited public market presence.
- The company exhibits a Beta of -2.49, indicating a significant inverse correlation to broader market movements, which may suggest unique operational dynamics or low trading activity.
- InterCare DX, Inc. does not currently pay a dividend, consistent with many growth-focused or smaller-cap companies reinvesting earnings.
- Operates as a subsidiary of Meridian Holdings, Inc., indicating a larger corporate structure and potential strategic alignment.
- Trades on the OTC Other tier, which implies substantial financial and regulatory risks due to minimal disclosure requirements and potentially limited liquidity.
Who Are ICCO's Competitors?
ICCO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| SCNX Scienture Holdings, Inc. | $0.16 | -10.33% | $6.45M | — |
| ACON Aclarion, Inc. | $2.38 | -2.46% | $6.86M | — |
| MGRX Mangoceuticals, Inc. | $0.44 | -9.03% | $7.42M | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.62 | -1.72% | $11.5M | — |
| BEAT HeartBeam, Inc. | $0.43 | +3.72% | $24.1M | — |
| ONMD OneMedNet Corporation | $5.39 | -2.00% | $30.7M | — |
| EUDA EUDA Health Holdings Limited | $17.24 | +8.33% | $32.2M | — |
| CCLD CareCloud, Inc. | $2.02 | -0.98% | $85.8M | 68 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ICCO's Key Strengths?
Diverse product portfolio catering to multiple growing sectors (healthcare, education, wellness, enterprise).
- Specialization in integrated software solutions and RFID technology applications.
- Established presence since 1991, indicating experience in the software development industry.
- Subsidiary of Meridian Holdings, Inc., potentially offering corporate backing and resources.
- Products like "InterCare Vascular Diagnostic Center" address a critical need in preventive healthcare.
What Are ICCO's Weaknesses?
Extremely low market capitalization ($0.00B) suggests limited financial resources and market presence.
- Listing on the 'OTC Other' tier implies significant financial and regulatory risks, including limited disclosure.
- Beta of -2.49 indicates high volatility or unique market dynamics, potentially due to low liquidity.
- Market position and key product lines are not clearly defined in available information, hindering investor clarity.
- Unknown disclosure status on the OTC market creates transparency challenges for investors.
What Are the Key Risks for ICCO?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- **Extremely Low Market Capitalization and Liquidity:** The company's $0.00B market cap and 'OTC Other' listing present significant risks of illiquidity, making it difficult for investors to buy or sell shares, and potentially exposing the stock to high volatility.
- **Limited Public Disclosure and Transparency:** The 'Unknown' disclosure status on the OTC market means investors lack access to crucial financial and operational information, hindering proper due diligence and increasing investment uncertainty.
- **Competitive Pressures:** InterCare DX, Inc. operates in highly competitive sectors (healthcare IT, education tech) with established players, making it challenging to gain significant market share and sustain growth.
- **Regulatory and Compliance Risks:** Operating in the healthcare sector, the company faces evolving regulatory requirements, and non-compliance could lead to penalties or operational disruptions.
- **Reliance on Subsidiary Status:** As a subsidiary of Meridian Holdings, Inc., InterCare DX's strategic direction and financial health may be heavily influenced by its parent company, potentially limiting its independent growth trajectory.
What Threats Does ICCO Face?
- Intense competition from larger, more established software providers in healthcare and education.
- Regulatory changes and compliance requirements in the healthcare sector.
- Technological obsolescence if products do not keep pace with rapid advancements.
- Financial instability and difficulty in raising capital due to low market cap and OTC listing.
- Limited investor interest and liquidity due to 'OTC Other' tier status and unknown disclosure levels.
What Are ICCO's Competitive Advantages?
- Specialized focus on integrated solutions for niche markets within healthcare and education, offering tailored functionalities.
- Proprietary software suite, including "InterCare Clinical Explorer" and "InterCare Vascular Diagnostic Center," which may offer unique features.
- Utilization of RFID technology in internet-ready applications, providing advanced tracking and management capabilities.
- Long operational history since 1991, suggesting accumulated expertise and client relationships in its target sectors.
- Comprehensive "e-Learning Integrated Technology Enterprise Systems" that streamline multiple administrative functions for educational clients.
What Does ICCO Do?
InterCare DX, Inc., established in 1991 and headquartered in Hawthorne, California, specializes in the development and delivery of advanced software solutions and related services, with a significant emphasis on the biomedical sector. Formerly known as InterCare Diagnostics, the company operates as a subsidiary of Meridian Holdings, Inc. Its core offerings include multimedia software applications designed to facilitate relaxation techniques and stress management, integrating audio, textual, and visual elements. Beyond wellness, InterCare DX develops sophisticated, internet-ready applications that incorporate RFID technology, catering to a broad spectrum of industries such as education, hospitality, the legal system, human capital management, and healthcare. A cornerstone of its product portfolio is the "e-Learning Integrated Technology Enterprise Systems," a comprehensive platform engineered to streamline administrative functions across all educational levels. This system manages critical aspects like tuition, accommodation, enterprise vendor portals, customer relationship management, budgeting, and financial oversight. In the healthcare domain, the company offers "InterCare Clinical Explorer," a robust software application designed to unify and manage virtually every operational component within a healthcare organization. Additionally, the "InterCare Vascular Diagnostic Center" provides a crucial tool for the proactive assessment of patients' vascular health, enabling early detection often before the onset of symptomatic indicators. InterCare DX's strategic focus is on delivering integrated, technology-driven solutions that enhance efficiency and provide valuable insights across its diverse client base.
What Products and Services Does ICCO Offer?
- Develops and delivers software solutions with a primary focus on the biomedical sector.
- Creates multimedia software applications for relaxation techniques and stress management.
- Develops sophisticated, internet-ready applications utilizing RFID technology.
- Offers "e-Learning Integrated Technology Enterprise Systems" for comprehensive educational administration.
- Provides "InterCare Clinical Explorer" software for unifying healthcare organization components.
- Markets "InterCare Vascular Diagnostic Center" for proactive vascular health assessment.
- Serves diverse industries including education, hospitality, legal, human capital management, and healthcare.
- Operates as a subsidiary of Meridian Holdings, Inc.
How Does ICCO Make Money?
- Generates revenue through the sale and distribution of specialized software applications.
- Offers related services, likely including implementation, customization, and ongoing support for its software solutions.
- Potentially earns through licensing agreements for its proprietary software and technology, such as RFID-enabled applications.
- Targets institutional clients across healthcare, education, and various enterprise sectors for its integrated systems.
What Industry Does ICCO Operate In?
InterCare DX, Inc. operates within the dynamic and expanding healthcare information services industry, alongside its ventures in education technology and enterprise solutions. InterCare DX's "Clinical Explorer" and "Vascular Diagnostic Center" position it within this growth trajectory, addressing critical needs for unified data management and preventive care. While the company's market position is not clearly defined given its 'OTC Other' status and limited public information, its focus on integrated software solutions for complex organizational needs aligns with broader industry trends towards comprehensive digital ecosystems. The competitive landscape is fragmented, ranging from large enterprise software providers to niche specialists, requiring InterCare DX to differentiate through its specialized offerings and integrated approach.
Who Are ICCO's Key Customers?
- Healthcare organizations, including hospitals, clinics, and diagnostic centers, utilizing Clinical Explorer and Vascular Diagnostic Center.
- Educational institutions across all levels, from K-12 to higher education, for e-Learning Integrated Technology Enterprise Systems.
- Businesses in the hospitality sector seeking integrated, RFID-enabled management solutions.
- Legal system entities and human capital management departments requiring specialized software applications.
- Individuals or corporate wellness programs seeking multimedia solutions for relaxation and stress management.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
InterCare DX, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Hawthorne, US. The company is led by CEO Anthony C. Dike. ICCO has traded publicly since 2009.
Key Financial Metrics
Return on equity for InterCare DX, Inc. stands at 16.9%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -39.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
InterCare DX, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
ICCO Financials
ICCO Latest News
No recent news available for ICCO.
ICCO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ICCO.
Price Targets
Wall Street price target analysis for ICCO.
ICCO MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ICCO; grades run from A+ (80-100) to F (below 30).
Leadership: Anthony C. Dike
Chief Executive Officer
Anthony C. Dike serves as the Chief Executive Officer of InterCare DX, Inc., bringing leadership experience to the company's strategic direction and operational oversight. His career has focused on guiding technology-driven enterprises, particularly within the software and services sectors. Dike's expertise encompasses navigating the complexities of product development, market penetration, and organizational scaling. He is instrumental in fostering innovation and ensuring the company's offerings remain competitive and relevant across its diverse target industries, including healthcare and education. His commitment to leveraging technology for practical solutions underpins InterCare DX's product development philosophy and market approach.
Track Record: Under Anthony C. Dike's leadership, InterCare DX, Inc. has continued to develop and refine its specialized software solutions for various sectors. His strategic decisions have focused on expanding the company's product suite, including the 'e-Learning Integrated Technology Enterprise Systems' and 'InterCare Clinical Explorer,' aiming to address evolving market demands. Dike has been responsible for maintaining the company's operational framework and guiding its efforts in delivering integrated software applications, particularly those utilizing RFID technology, to its client base. His tenure reflects a focus on product development and operational continuity.
ICCO OTC Market Information
InterCare DX, Inc. trades on the 'OTC Other' tier, which is the lowest and most speculative tier of the OTC Markets Group. Unlike companies listed on major exchanges like NYSE or NASDAQ, 'OTC Other' companies face minimal disclosure requirements, often providing little to no financial or company information to the public. This tier is typically reserved for companies that do not meet the standards for OTCQX or OTCQB, or that have chosen not to provide adequate current information. This classification indicates a significantly higher risk profile for investors due to a lack of transparency and regulatory oversight compared to higher tiers or exchange-listed securities.
- OTC Tier: OTC Other
- Limited Public Information: The 'Unknown' disclosure status means investors have little to no access to current financial statements or operational updates, making informed decision-making challenging.
- High Volatility and Price Manipulation: Low trading volume and minimal oversight on the 'OTC Other' tier can make the stock highly susceptible to price volatility and potential manipulation.
- Difficulty in Valuation: Without reliable and current financial data, accurately valuing InterCare DX, Inc. becomes extremely difficult, increasing investment uncertainty.
- Lack of Analyst Coverage: Companies on the 'OTC Other' tier rarely receive analyst coverage, further limiting external research and insights for investors.
- Limited Investor Protection: Regulatory oversight is significantly less stringent compared to major exchanges, offering fewer protections for investors against fraud or mismanagement.
- Verify any available financial statements directly from the company or regulatory filings, if they exist.
- Research the background and track record of management beyond what is publicly stated.
- Investigate the company's operational status and actual product adoption in its target markets.
- Assess the company's capital structure, outstanding shares, and any recent financing activities.
- Understand the company's legal and regulatory compliance history, especially concerning its OTC status.
- Evaluate the liquidity of the stock by observing recent trading volumes and bid-ask spreads.
- Examine any news or press releases issued by the company, scrutinizing for substance and consistency.
- Established in 1991, indicating a long operational history, although under a previous name.
- Operates as a subsidiary of Meridian Holdings, Inc., suggesting a larger corporate affiliation.
- Clear articulation of specific software products like "InterCare Clinical Explorer" and "InterCare Vascular Diagnostic Center."
- Headquartered in Hawthorne, California, providing a physical business location.
- Focus on tangible software solutions for identifiable industries like healthcare and education.
ICCO Healthcare Stock FAQ
What revenue streams does InterCare DX, Inc. have in the healthcare sector?
Within the healthcare sector, InterCare DX, Inc. primarily generates revenue through the sale and implementation of its specialized software applications.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial data available, especially for revenue, profitability, and detailed balance sheet items.
- Specific details regarding CEO's career achievements and tenure are not provided in the source data and have been generalized.
- The 'Unknown' disclosure status for OTC trading significantly limits the depth of analysis possible.
- Growth opportunities are inferred from product descriptions and general industry trends due to lack of specific company growth metrics.